Although pulse wave velocity is the primary indicator of arteriosclerosis and is widely used as an index of vascular age in anti-aging medicine, no index is available to quantify cardiac age. We proposed a "cardiac age" index and sought to clarify its clinical significance. The study subjects were 234 patients with atherosclerosis-related diseases. These patients were divided into 127 normotensive (mean age: 64 ± 12 years) and 107 hypertensive (mean age: 65 ± 11 years) patients. Echocardiography was performed, and brachial-ankle pulse wave velocity (baPWV) was measured using an automatic waveform analyzer. The index of cardiac 
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Introduction
Both carotid ultrasonography and pulse wave velocity are established means of diagnosing arteriosclerosis ( 1 -5 ) . In particular, because pulse wave velocity can reflect arterial stiffening due to arteriosclerosis, it is a useful index of vascular age in clinical settings of anti-aging medicine ( 3 -5 ) . In contrast, no indexes of cardiac age have been derived from echocardiography. This may be attributable to the fact that echocardiography has mainly been used for diagnosing cardiac disease and assessing cardiac function.
However, with the advent of echocardiography, numerous reports have revealed that the sigmoid septum is the result of a cardiac morphological change that occurs due to aging ( 6 , 7 ) . This cardiac malformation is a structural change, characteristic of a diminished angle between the basal ventricular septum and the ascending aorta ( 8 , 9 ) . The sigmoid septum has been considered the result of aging and has not been thought to have any pathophysiologic or clinical significance (6) (7) (8) (9) in most elderly people; however, several reports have demonstrated that a sigmoid septum sometimes causes a significant narrowing of the left ventricular outflow tract (10, 11) . We propose a new cardiac age index for the quantitative assessment of age-related changes in the heart and ascending aorta by measuring the sigmoidity of the left ventricular septum. We hypothesize that this index, which quantifies agerelated cardiac structural changes assessed by echocardiography, correlates with the real cardiac age of patients.
The purpose of the present study was to propose a new index of cardiac age that is easily measured using echocardiography and to clarify the clinical significance of the index.
Methods
Subjects and Protocol
The study subjects were 234 patients aged 40-80 years (mean age: 65 ±12 years) who were diagnosed as having atherosclerosis-related diseases at Sakaide Municipal Hospital between April 2004 and the end of March 2007. Atherosclerosis-related diseases included hypertension, diabetes mellitus, and dyslipidemia, which were diagnosed according to the guidelines of the Japanese Society of Hypertension (12), the Japan Diabetes Society (13) , and the Japan Atherosclerosis Society (14) . Informed consent was obtained from all of the participants. None of the subjects had a history of any atherosclerotic cardiovascular diseases or stroke. Blood pressure was determined using the conventional cuff method at the time when the echocardiographic examination was performed. An echocardiograph was performed to assess cardiac structural changes and cardiac function. The patients were divided into normotensive and hypertensive groups, based on the criteria proposed by the Japanese Society of Hypertension in 2004 (12) . Hypertension was defined as systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure of ≥ 90 mmHg. Normotension was defined as systolic blood pressure < 140 mmHg and diastolic blood pressure < 90 mmHg. From our diagnosis 107 patients (mean age: 65±11 years) had hypertension (hypertensive group) and 127 patients (mean age: 64 ±12 years) did not have hypertension (normotensive group). Clinical characteristics, including blood pressure and echocardiographic findings, were compared between the groups. This protocol was approved by the Ethics Committee of Sakaide Municipal Hospital.
Echocardiographic Examination
Two-dimensional and M-mode echocardiography were performed using an echocardiographic instrument (Vivid Seven System; GE Vingmed, Horten, Norway). We first measured the following left ventricular structural parameters: the ventricular septal thickness at the left ventricular outflow tract (VSot), the angle between the ventricular septum and the ascending aorta (VS-AO), the ventricular septal thickness at the chordae tendineae level (VS), the left ventricular enddiastolic dimension at the chordae tendineae level (LVDd), the left ventricular posterior wall thickness at the chordae tendineae level (PW), and the end-systolic dimension of the left atrium (LAD). In all subjects, the echocardiographic examination was carried out by the same sonographer. Measurement of the above-mentioned parameters was performed by two physicians who had no medical information about the subjects. The VSot and VS-AO were measured at the end- Fig. 1 Index of cardiac age = 1,000 VS ot /BSA/(VS-AO) diastolic phase by two-dimensional echocardiography (Fig.  1 ). We drew a straight line on the internal edge of the ascending aorta wall and another straight line on the right ventricular edge of the ventricular septum in order to measure the VS-AO. The VS-AO was measured as the angle between the two lines. When it was difficult to draw a straight line on the right ventricular edge of the ventricular septum in a subject with a severe sigmoid septum, we drew another straight line on the left ventricular edge of the ventricular septum. Thus, we determined the straight line on the right ventricular edge of the ventricular septum by trying to make the two lines parallel. The VS, LVDd, PW, and LAD were measured by Mmode echocardiography. The left ventricular ejection fraction (LVEF) was estimated by Teichholz's method (15) . We determined the index of cardiac age by the following equation:
Index of cardiac age = 1,000 × VSot/BSA/(VS-AO), where VSot (mm) is the ventricular septal thickness at the left ventricular outflow tract, BSA (m 2 ) is the body surface area, and VS-AO (degree) is the angle between the basal ventricular septum and the ascending aorta (Fig. 1) . We selected VSot and VS-AO as factors of the equation mentioned above because it is well known that left ventricular wall thickness increases with advancing age in normotensive patients even if the left ventricular mass index (LVMI) does not change (16) . In addition, the VS-AO was expected to decrease with advancing age because of the sigmoid septum. Therefore, we believed it was likely that the index of cardiac age described above would increase with advancing age. The value of VSot/ BSA/(VS-AO) reflects both age-related thickening of the basal ventricular septum normalized by body surface area and the extent of the sigmoid septum. In the present study, we 
is the body surface area, and VS-AO (degree) is the angle between the basal ventricular septum and the ascending aorta. The index of cardiac age is 51 in a normotensive patient whose real age is 56 years (left). In contrast, the index of cardiac age is 87 in a hypertensive patient whose real age is 48 years (right).
Normotensive male patient, 56 years old multiplied VSot/BSA/(VS-AO) by 1,000 to show the index of cardiac age as a number in double or triple figures. Thus, this index may be useful because we can compare its value with the real age of a patient. For example, the index of cardiac age was 51 in a normotensive patient whose real age was 56 years (Fig. 2, left) . In contrast, the index of cardiac age was 87 in a hypertensive patient whose real age was 48 years (Fig. 2 , right). The index of cardiac age was lower than the real age of the normotensive patient but higher than that of the hypertensive patient.
The left ventricular mass was calculated according to the American Society of Echocardiography convention (17) using the following formula:
The LVMI was calculated as the left ventricular mass divided by the BSA. We next measured the parameters of left ventricular diastolic function by recording the left ventricular diastolic inflow using pulsed Doppler echocardiography (18) . The left ventricular diastolic filling pattern was recorded from the apical transducer position with the sample volume situated between the mitral leaflet tips. The peak velocity of early rapid filling (E velocity) and the peak velocity of atrial filling (A velocity) were recorded, and the ratio of E to A (E/A ratio) was calculated. The deceleration time of the E velocity (DcT) BMI, body mass index; BSA, body surface area; BP, blood pressure; baPWV, brachial-ankle pulse wave velocity; ACEI, angiotensinconverting enzyme inhibitors; ARB, angiotensin-II receptor blockers; CCB, calcium channel blockers; VSot, ventricular septal thickness at left ventricular outflow tract; VS-AO, angle between the ventricular septum and the ascending aorta; VS, ventricular septal thickness at the chordae tendineae level; PW, posterior wall thickness at the chordae tendineae level; LVDd, left ventricular end-diastolic dimension at the chordae tendineae level; LVMI, left ventricular mass index; LVEF, left ventricular ejection fraction; LAD, left atrial dimension; E, peak early diastolic transmitral flow; A, peak late diastolic transmitral flow; E/A, the ratio of E to A; DcT, deceleration time of early diastolic transmitral flow; n.s., not significant.
was measured as the time interval from the E-wave peak to the return of the velocity to baseline values.
Assessment of Pulse Wave Velocity
Brachial-ankle pulse wave velocity (baPWV) was measured using an automatic waveform analyzer (Form/ABI, OmronColin Co. Ltd., Komaki, Japan). This measurement was not performed on all patients, but was performed on 101 normotensive patients and 42 hypertensive patients. Details of the methodology have been described elsewhere (3) (4) (5) . Measurements were taken with subjects lying in a supine position after resting for at least 5 min. Electrocardiographic electrodes were placed on both wrists and cuffs were wrapped on the bilateral brachia and ankles. Pulse volume waveforms at the brachium and ankle were recorded using a semiconductor pressure sensor.
Statistical Analysis
Data are expressed as means±SD. Statistical analysis was performed using the SPSS software package (SPSS, Chicago, USA). An unpaired Student t-test was performed to compare the variables between the normotensive and hypertensive groups. Linear regression analysis was performed to evaluate the association between the index and other variables.
Stepwise multiple regression analysis was performed to determine the correlation between the index and each independent variable. Values of p< 0.05 were considered to indicate statistical significance.
Results
Comparison of Clinical and Ultrasonographic Characteristics between Normotensive and Hypertensive Patients
The clinical and echocardiographic results for the patients in the present study are summarized in Table 1 . The age and body surface area were similar between normotensive and hypertensive patients. Blood pressure and baPWV were significantly higher in hypertensive patients than in normotensive patients (p< 0.001 and p< 0.05, respectively). VSot was significantly higher and VS-AO significantly lower in hypertensive patients than in normotensive patients (p< 0.001). Thus, the index of cardiac age was significantly higher in hypertensive patients than in normotensive patients (p< 0.001). The LVMI was significantly higher and the E/A significantly lower in hypertensive patients than in normotensive patients (p< 0.05 and p< 0.001, respectively).
Association between Index of Cardiac Age and Other Variables
Linear regression analysis was performed to examine the relationship between the index of cardiac age and other variables in all subjects (normotensive and hypertensive patients combined). The significant associated parameters are shown in Table 2 . The index correlated with age (r= 0.57, p< 0.001), the presence of hypertension (r= 0.37, p< 0.001), baPWV (r= 0.53, p< 0.001), and E/A (r= −0.52, p< 0.001). We analyzed the relationship between the index and age in normotensive and hypertensive patients (Fig. 3, left) . The index tended to be higher in hypertensive patients than in normotensive patients in all age strata. The slope between age (xaxis) and the index of cardiac age (y-axis) was greater in hypertensive (1.50) than normotensive (1.32) patients. In addition, we analyzed the relationship between E/A and age in each group (Fig. 3, right) . The E/A in hypertensive patients tended to be lower than that in normotensive patients in all age strata. The correlation between the index and age (normotensive: r= 0.63, p< 0.001; hypertensive: r= 0.58, p< 0.001) was closer than that between E/A and age (normotensive: r= 0.54, p< 0.001; hypertensive: r= 0.44, p< 0.001) in both normotensive and hypertensive patients. 
Assessment of the Factors Related to Index of Cardiac Age
Stepwise multiple regression analysis was performed to identify which of the parameters were independently associated with the index of cardiac age. The present study included the patients who did not undergo baPWV. For all patients, the stepwise multiple regression analysis (model 1) was performed for age, hypertension, diabetes mellitus, dyslipidemia, heart rate, systolic blood pressure, diastolic blood pressure, LVDd, LVMI, LVEF, LAD, E/A, and DcT; see Table 2 . This analysis indicated that age (β coefficient= 0.35, p< 0.001), the presence of hypertension (β coefficient= 0.26, p< 0.001), LVMI (β coefficient= 0.34, p< 0.001), LVDd (β coefficient= −0.35, p< 0.001), LAD (β coefficient= 0.14, p= 0.014), and the ratio of E to A (E/A) (β coefficient= −0.12, p= 0.046) were independently associated with the index (Table 3) . For patients who underwent baPWV, the stepwise multiple regression analysis (model 2) was performed for the same parameters above plus baPWV. This analysis indicated that age (β coefficient= 0.42, p< 0.001), the presence of hypertension (β coefficient= 0.25, p< 0.001), and the baPWV (β coefficient= 0.22, p= 0.008) were independently associated with the index (Table 4) . Thus, among the clinical factors, only age and the presence of hypertension were independently associated with the index in both model 1 and model 2. Figure 4 shows the relationship between the index and baPWV in 143 patients whose baPWV could be measured in the present study. The correlation between the index and baPWV (r= 0.53, p< 0.001) was closer than that between LVMI and baPWV (r= 0.27, p= 0.001).
Relationship between Index of Cardiac Age and baPWV
Discussion
The present study proposed a new index of cardiac age. The LVMI, left ventricular mass index; LVDd, left ventricular enddiastolic dimension at the chordae tendineae level; LAD, endsystolic dimension of the left atrium; A, peak late diastolic transmitral flow; E, peak early diastolic transmitral flow; E/A, the ratio of E to A. baPWV, brachial-ankle pulse wave velocity. data led us to the following conclusions: 1) The proposed index demonstrates a good correlation with age, and this correlation is as close as that between E/A and age in both normotensive and hypertensive patients; 2) the index is higher in hypertensive patients than in normotensive patients, and the index increases more with advancing age in hypertensive patients than in normotensive patients; 3) the index demonstrates a good correlation with baPWV, and the correlation is closer than that between LVMI and baPWV.
It is well known that the value of E/A is influenced by aging and demonstrates a good correlation with age (19, 20) . In addition, several previous studies (21, 22) reported that E/A was lower in hypertensive patients than in normotensive patients. In the present study, the data regarding the relationship between E/A and age agreed with those of previous studies (19, 20) . The data in the present study demonstrated that the correlation of the proposed index with age was as close as that of E/A with age in both normotensive and hypertensive patients (Fig. 3) . Thus, the proposed index may be a useful marker in the assessment of cardiac age in both normotensive and hypertensive patients.
Systolic arterial pressure increases with aging due, in part, to arterial stiffening (23, 24) . The heart and vasculature of normotensive elderly subjects take on the appearance of "muted" hypertension (25) . Younger hypertensive patients exhibit many of the same characteristics as older normotensives, such as cardiac hypertrophy (26) , increased vascular stiffness (25, 27) , and increased aortic impedance (28) . Thus, aging has sometimes been referred to as blunted hypertension, and hypertension has been described as accelerated aging (23, 24) . Therefore, the increase in the index of cardiac age in the present study may represent cardiac and aortic adaptation to arterial stiffening in aging or hypertension. This increase in arterial stiffening in aging or hypertension is likely to be a reason why both age and the presence of hypertension were independently associated with the index (Table 3) .
Clinical Implications
The linear regression analysis showed that the proposed index correlated significantly with the pulse wave velocity. Furthermore, stepwise regression analysis showed that the baPWV was independently associated with the proposed index for the patients who underwent baPWV. This suggests that the proposed index may reflect arteriosclerosis as well as the pulse wave velocity.
In addition, the present study showed that the proposed index has the advantage of independence from blood pressure at the time the index is measured (Table 2) . It is well known that pulse wave velocity is influenced by blood pressure at the time the velocity is measured (29) . In clinical settings, some patients have not paid attention to their own blood pressure and, thus, have unclear histories of hypertension. The proposed index may be useful for presuming the existence of hypertension in these patients.
Moreover, the present study demonstrated considerably high Pearson's correlation coefficients of interobserver (r= 0.96, p< 0.001) and intraobserver (r= 0.99, p< 0.001) reproducibility by analyzing the data for all subjects. The reproducibility of the proposed index measurement is acceptable in clinical practice.
Study Limitations
First, we have no data for assessing the prognostic value of the increase in the proposed index in hypertensive patients. It is well known that left ventricular hypertrophy detected via an increase in left ventricular mass predicts an increased risk for cardiovascular disease in patients with essential hypertension (30) . Schillaci et al. demonstrated an independent relationship between E/A and the risk of cardiovascular events in untreated hypertensive patients by analyzing the results of a prospective follow-up study of Caucasian adult patients with essential hypertension (31) . LVMI is slightly increased with normal aging. In addition, coronary flow reserve remarkably decreases and cardiac diastolic function deteriorates with normal aging. The decrease in E/A with normal aging reflects age-related changes in cardiac diastolic function. In contrast, the proposed index reflects cardiac morphological changes with aging. The presents study demonstrated that E/A is an independent determinant for the proposed index (Table 3) . However, the clinical significance of the proposed index may be different from that of E/A. Therefore, a prospective followup study is needed in order to validate the usefulness of the proposed index.
Second, we have no data regarding whether or not antihypertensive therapy leads to a decrease in the proposed index. Further study is needed in order to assess the effect of treatment on the proposed index in hypertensive patients.
Third, we have no data regarding new indexes of diastolic dysfunction such as tissue Doppler imaging-derived mitral E/e′ or brain natriuretic peptide. In addition, we have no data on subjects with diastolic dysfunction. Moreover, exercise capacity is also affected by cardiac aging. Therefore, further study is needed to validate the proposed index by comparing it to other indexes (e.g., exercise capacity) for which agerelated changes have been established.
Fourth, we obtained no data from normal volunteers with no atherosclerosis-related diseases in the present study. Although the proposed index potentially estimates the individual cardiac aging process, data obtained from normal volunteers are needed in order to assure this possibility. A prospective follow-up study in normal volunteers is also needed so that the results can be compared with those obtained from patients with atherosclerosis-related diseases. In addition, the subjects in the present study might include patients who showed a pseudonormal left ventricular filling pattern due to their atherosclerosis-related diseases such as hypertension.
Fifth, the proposed index is influenced by the left ventricular wall thickness, which is increased in hypertensive patients. However, other risk factors were not selected as independent variables for the proposed index in the present study. Further investigation is needed to elucidate effects of other risk factors on cardiac age.
Finally, we only analyzed the relationships of the proposed index to age, blood pressure, pulse wave velocity, and risk factors of atherosclerosis in the present study. Although the proposed index showed a close correlation with age, we cannot definitively say that the proposed index itself can represent cardiac age. Further study is needed to develop a new equation that can determine cardiac age.
Conclusions
In conclusion, the proposed index of cardiac age can quantitatively assess the cardiac morphological changes that occur due to aging and/or hypertension. It may, therefore, be a clinically useful indicator of cardiac aging, which is produced by vascular aging and/or hypertension. In addition, it may be a useful marker of peripheral arterial stiffening because of the close correlation with brachial-ankle pulse wave velocity.
